Investors
David J. Brailer, MD, PhD
Ned Brown
Sarah Chang
Thomas P. Chung
Rolf Classon
Bradley M. Fluegel
Adam Grossman
Aadam Hussain
Braden Kelly
Christopher McFadden
Julie Murchinson
Peter Neupert
Carter Paine
Reid S. Perper
Jay B. Rose, MD
Joshua Saipe
Barry Smith
Kevin Tseng
Jacqueline Valdez
Kay Yun
Carl Zimmerman
Christopher D. McFadden, CFA
Managing Partner
cmcfadden@healthevolutionpartners.com
Chris manages the Health Evolution Partners Spectrum Fund and is a member of the Health Evolution Partners Spectrum Fund’s Commitment Committee.
Boards of Directors
Foundation Radiology Group
Mauna Kea Technologies
Former member, Prematics (sold to Navinet)
Former member, Picis Solutions (sold to UnitedHealth Group)
Select Prior Experience:
Goldman, Sachs & Co.: Chris joined Goldman, Sachs & Co. in 1999 as a vice president and was named managing director in 2004. He most recently directed debt and equity investments in private and public North American-based health care companies as part of Goldman Sachs’ Americas Special Situations Group (AmSSG). From 1999 to 2006, Chris was a senior equity research analyst responsible for Goldman Sachs’ US health care services research coverage and served as a member of the Global Investment Research Sounding Board.
Wheat First Securities: Prior to joining Goldman, Sachs, Chris was a senior research analyst with Wheat First Securities, now Wells Fargo Securities.
Community:
Former chairman of the advisory board, Philip Coltoff Center of the Children’s Aid Society
Founder, RAMP, a mentoring program for undergraduate students
Trustee, Montefiore Medical Center in New York
Trustee, Natural History Museum of the Adirondacks
Education:
Bachelor’s degree, political science, University of Richmond
Chartered Financial Analyst (CFA)
